Nano-drug delivery system targeting FAP for the combined treatment of oral leukoplakia

Abstract

Oral leukoplakia (OLK) has received much attention due to its potential risk of malignant transformation.Studies have shown that when drug therapy is combined with photothermal therapy (PTT), not only can the cytotoxicity of the drug be enhanced, but also the heat energy can be used to kill the lesion cells, so we can combine drug therapy with PTT to enhance the therapeutic effect on OLK. However, with certain drawbacks due to its lack of targeting, broblast activating protein (FAP) has become an attractive target for OLK combination therapy. In this study, we used NGO-PEG loaded with FAP-targeting peptide and celecoxib (CXB) to construct a nano-drug delivery system CGPF for targeting OLK with high FAP expression, and con rmed the biocompatibility and therapeutic e cacy of CGPF by in vitro and in vivo experiments. Overall, the novel nano-drug delivery system CGPF proposed in this study showed a very signi cant potential for the combination therapy of OLK.